Phase 2 Prostate Cancer Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed with prostate cancer, whether or not they have already received treatment for it
- People who have signed a written consent form agreeing to take part
Who may not be able to join:
- People who have a known allergy to PSMA (a protein found on prostate cancer cells)
- People who have a health condition that, in the medical team's judgement, could significantly affect their ability to follow the study requirements
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Weibing Miao, MD, First Affiliated Hospital of Fujian Medical University
Phone: 86-0591-87981618
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Number of participants with Imaging Emergent Adverse Events; Dosimetry data
Can't join this trial?
Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.